Naučne publikacije akademskog osoblja


Za tačnost unetih podataka o publikacijama, naučnim i umetničkim referencama odgovorni su autori.
Datum kreiranja: 30.11.2022.

Milovan Stojanović

Dodatne informacije

  • Lični podaci

  • Datum rođenja: 07.03.1987.
  • Mesto rođenja: Novi Sad
  • Obrazovanje

  • Fakultet: Medicinski fakultet Niš
  • Odsek / Grupa / Smer: Medicina
  • Godina diplomiranja: 2012.
  • Spisak publikacija

  • Radovi u časopisima sa IMPACT faktorom:

    1. Koracevic G, Lovic D, Zdravkovic M, Stojanovic M. Long-lasting, resistant hypertension should be a part of the aortic dissection risk score. Hypertens Res 2019;42(11):1836-1838.doi: 10.1038/s41440-019-0305-8.

    2. Koracevic G, Stojanovic M, Kostic T, Lovic D, Tomasevic M, Jankovic-Tomasevic R. Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin. Med Princ Pract 2020;29(4):301-309. doi: 10.1159/000508462.

    3. Koracevic G, Stojanovic M, Lovic D, Djordjevic D. Impending hypertensive emergency is frequently considered in guidelines, but neither defined nor explained. Blood Press 2020;29(5):336-337. doi: 10.1080/08037051.2020.1769467.

    4. Koracevic G, Lovic D, Zdravkovic M, Stojanovic M, Djordjevic D. How should we treat very high blood pressure until we distinguish between hypertensive emergency and urgency? Hypertens Res 2020;43(5):470-472. doi: 10.1038/s41440-019-0393-5.

    5. Koracevic G, Micic S, Stojanovic M, Tomasevic M, Kostic T, Velickovic Radovanovic R, Lovic D, Djordjevic D, Randjelovic M, Koracevic M, Ristic Z. Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies. Hypertens Res 2020;43(7):591-596. doi: 10.1038/s41440-020-0449-6.

    6. Koracevic G, Mićić S, Stojanović M, Zdravković M, Kostić T, Koraćević M, Kutlešić M, Pavlović M, Dakić S. High likelihood for atrial fibrillation in Cushing's syndrome. Eur Rev Med Pharmacol Sci 2020;24(3):1391-1397. doi: 10.26355/eurrev_202002_20196.

    7. Stojanovic M, Deljanin-Ilic M, Ilic S, Ilic B. Isolated nocturnal hypertension: an unsolved problem when to start treatment and how low should we go? J Hum Hypertens 2020;34(10):739-740. doi: 10.1038/s41371-020-00403-5.

    8. Koraćević G, Mićić S, Stojanović M, Tomašević M, Kostić T, Koraćević M, Janković I. Single prognostic cut-off value for admission glycemia in acute myocardial infarction has been used although high-risk stems from hyperglycemia as well as from hypoglycemia (a narrative review). Prim Care Diabetes 2020:S1751-9918(20)30280-1. doi: 10.1016/j.pcd. 2020.09.004.

    9. Koracevic G, Lovic D, Stojanovic M, Djordjevic D, Koracevic M. Hypertensive emergency is characterized by acute hypertension-mediated organ damage but also a life-threatening status. Hypertens Res 2020;43(12):1457-1458. doi: 10.1038/s41440-020-0501-6. 

    10. Koracevic G, Micic S, Stojanovic M. By discontinuing beta-blockers before an exercise test we may precipitate a rebound phenomenon. Curr Vasc Pharmacol 2021 Mar 2. doi: 10.2174/1570161119666210302152322.

    11. Koracevic G, Micic S, Stojanovic M, Lovic D, Simic D, Colic M, Koracevic M, Stojkovic A, Paunovic M. Compelling Indications Should Be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class. Curr Vasc Pharmacol 2021;19(4):343-346. doi: 10.2174/1570161118666200518113833.

    12. Koracevic G, Stojanovic M, Lovic D, Zdravkovic M, Sakac D. Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk. J Hum Hypertens 2021 Mar 2. doi: 10.1038/s41371-021-00505-8.

    13. Koraćević G, Stojković M, Stojanović M, Zdravković M, Simić D, Šalinger-Martinović S, Đorđević D, Damjanović M, Đorđević-Radojković D, Koraćević M. Less Known but Clinically Relevant Comorbidities of Atrial Fibrillation: A Narrative Review. Curr Vasc Pharmacol. 2022. doi: 10.2174/1570161120666220819095215. Epub ahead of print. 

    14. Koraćević G, Stojanović M, Kostić T, Lović D, Zdravković M, Koraćević M, Pavlović D, Mićić S. Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class. Curr Pharm Des. 2021;27(40):4125-4132. doi: 10.2174/1381612827666210716162130.

    15. Koracevic G, Micic S, Stojanovic M, Radovanovic RV, Pavlovic M, Kostic T, Djordjevic D, Antonijevic N, Koracevic M, Atanaskovic V, Dakic S. Beta Blockers can Mask not only Hypoglycemia but also Hypotension. Curr Pharm Des. 2022;28(20):1660-1668. doi: 10.2174/1381612828666220421135523.

    16. Koracevic G, Perisic Z, Stanojkovic M, Stojanovic M, Zdravkovic M, Tomasevic M, Djordjevic D, Mladenovic K, Koracevic M, Trkulja J. A Discrepancy: Calcium Channel Blockers are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure. Med Princ Pract. 2022 Aug 31. doi: 10.1159/000526792. Epub ahead of print. 

    17. Koracevic G, Stojanovic M, Lovic D, Radovanovic RV, Koracevic M. Rationale for the Concept of Impending Hypertension-Mediated Organ Damage. Curr Vasc Pharmacol. 2022;20(2):127-133. doi: 10.2174/1570161120666220124105846.

    18. Koracevic G, Stojanovic M, Tomasevic M, Simic D, Lovic D, Tasic I. A solution to an almost unrecognizable problem: how can we treat a patient before differentiating between hypertensive urgency and emergency? Expert Opin Pharmacother. 2022 Feb;23(3):285-288. doi: 10.1080/14656566.2021.1999414.

    19. Stojanović M, Deljanin-Ilić M, Ilić S, Krstić I, Mitić V, Simonovic D. Prevalence   and echocardiographic characteristics of arterial hypertension in patients with atrial fibrillation: a single center study. J Biol Regul Homeost Agents 2019;33(4):1167-1170.

    20. Koracevic G, Obradovic S, Kostic T, Pavlovic M, Kutlesic M, Stojanovic M, Vasiljevic S, Koracevic M. Four varieties of diabetes mellitus in acute myocardial infarction. Vojnosanitetski Pregled 2019;76(1):1184-1189.">doi:

    21. Koracević LG, Stojanović M, Lović D. Is there an unrecognized type of masked hypertension -"weekend masked hypertension"? J Biol Regul Homeost Agents 2019;33(1):187-189.

    22. Stojanovic S, Deljanin-Ilic M, Ilic S, Stefanovic M, Petrovic D, Petrovic V, Stojanovic M. Adiponectin resistance parameter as a marker for high normal blood pressure and hypertension in patients with metabolic syndrome. Hippokratia 2020;24(1):3-7.

    23. Koraćević G, Stojanović M, Petrović S, Simić D, Sakač D, Vlajković M, Stevic M, Kocić M, Đorđević M, Koraćević M. Cushing's syndrome, a risk factor for venous thromboembolism is a candidate for guidelines. Acta Endocrinol (Buchar) 2020;16(2):123-128. doi:10.4183/aeb.2020.123 

    24. Stojanović M, Deljanin-Ilić M, Ilić S, Petrović D, Ilić B. The effects of cardiac rehabilitation on haemodynamic parameters measured by impedance cardiography in patients with coronary artery disease. Vojnosanitetski pregled 2020;(00):126-126. doi:

    25. Deljanin-Ilić M, Stojanović M, Ilić S. The effect of cardiovascular rehabilitation on physical strain tolerance-does gender really matter? Vojnosanitetski pregled 2021;(00):146-146. doi:

    26. Stojanovic M. The treatment of masked (uncontrolled) hypertension — Should psychiatrists be involved? The European Journal of Psychiatry 2021;35(3):202-203. doi:

    27. Stojanović M, Ilić B, Deljanin-Ilić M, Ilić, S. Electrical injury-induced atrial fibrillation: A case report. Vojnosanitetski pregled 2022; (00): 85-85. doi:

    28. Aleksić I, Stojanović S, Stamenković B, Kostić S, Stojanović M. Characteristics of atherosclerotic plaque and the thickness of the carotid artery intima-media complex in patients with rheumatoid arthritis. Vojnosanitetski pregled 2022; (00): 28-28. doi:

    29. Krstic I, Deljanin-Ilic M, Pejcic I, Vrbic S, Marinkovic D, Stojanovic M. The impact of trastuzumab therapy and cardiovascular risk factors on cardiac function in HER2-positive breast cancer patients. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS 2021; 35(6): 1803-1815.

    30. Sonja Stojanović, Bojana Stamenković, Jovan Nedović, Ivana Aleksić, Jelena Jovanović, Jovana Cvetković, Jasmina Jocić, Miljana Šarac, Novica Dimić, Marija Andjelković Apostolović, Milovan Stojanović. Risk Factors Associated with Coronavirus Disease 2019-Related Hospitalization in Rheumatoid Arthritis Patients. J Biol Regul Homeost Agents 2022; 36(4): 807-814.

  • Radovi u ostalim časopisima:

    1. Koraćević G, Stojković A, Janković-Tomašević R, Dimitrijević E, Petrović S, Pavlović M, Damjanovic M, Kostic T, Kutlesic M, Sokolovic M, Stojanović M. Systolic blood pressure is a valid marker of in-hospital survival in acute cardiogenic pulmonary edema: Analysis of 1.397 patients. Acta medica Medianae 2015;54(3):45-50.doi: 10.5633/amm.2015.0307

    2. Stojanović S, Deljanin-Ilić M, Ilić S, Ilić B, Stojanović M, Petrović D. Aortic dissection: The role of echocardiography in emergency unit: Case report. Acta facultatis medicae Naissensis 2016;33(1):69-74.doi: 10.1515/afmnai-2016-0008

    3. Stojanović M, Ilić B, Stojanović S, Ilić S, Deljanin-Ilić M. Perforation of the Right Ventricle as a Complication of Pericardiocentesis: A Case report. Acta facultatis medicae Naissensis 2016;33(2):141-146. doi: 10.1515/afmnai-2016-0016

    4. Stojanović M, Deljanin-Ilić M, Vuković A, Petrović D. Pulmonary valve insufficiency as a complication of radical surgical treatment of tetralogy of Fallot. Acta facultatis medicae Naissensis 2017;34(2):179-188. doi: 10.1515/afmnai-2017-0020

    5. Petrović D, Deljanin-Ilić M, Ilić B, Stojanović S, Stojanović M, Simonović D. Case report of the patient with acute myocardial infarction:'From flat line to stent implantation'. Acta facultatis medicae Naissensis 2017;34(4):329-337.doi: 10.1515/afmnai-2017-0036

    6. Stojanovic M, Deljanin-Ilic M, Ilic S, Ilic B, Petrovic D. Does HAS-BLED risk score underestimate the risk of bleeding in patients with triple antithrombotic therapy? Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2020;48(287):361-364.

    7. Petrović D, Deljanin-Ilić M, Stojanović S, Simonović D, Stojanović D, Mitić V, Stojanović M. Prognostic Value of the Right Ventricle Diameter, Pulmonary Arterial Pressure and Biomarkers in Patients with Acute Heart Failure. Acta facultatis medicae Naissensis 2021;38(2):116-124. doi: 10.5937/afmnai38-28538 

    8. Deljanin-Ilić M, Kocić G, Lazarević G, Simonović D, Stojanović M, Ilić S, Djordjevic B, Petrovic D, Stojanović, S. Exercise training and inflammatory markers in coronary artery disease patients. Acta facultatis medicae Naissensis 2022; 39(2): 173-184. doi: 10.5937/afmnai39-36545

    9. Ilić B, Stojanović M, Ilić DM. Treatment of arterial hypertension in the light of new guidelines. Srce i krvni sudovi 2014;33(4): 241-245.

    10. Simonović D, Ilić S, Nikolić A, Ilić B, Nikolić Lj, Ignjatović S, Stojanović M, Stojanović S, Pajić S. Prikaz bolesnika sa generalizovanom aterosklerozom. Balneoclimatologia 2015;39(1):251-262.

    11. Stojanović M, Nikolić M, Ilić S, Ilić B, Deljanin Ilić M. Novonastali blok desne grane u akutnom infarktu miokarda. Balneoclimatologia 2015;39(1):395-400.

    12. Ilić B, Marinković D, Petrović D, Nikolić Lj, Simonović D, Ignjatović S, Stojanović M, Stojanović S. Prikaz bolesnika sa akutnim koronarnim sindromom “Od ravne linije do stenta”. Balneoclimatologia 2015;39(1):219-228. 

    13. Ilić B, Deljanin Ilić M, Marinković D, Simonović D, Petrović D, Stojanović S, Stojanović M. Uporedni prikaz bolesnika sa aneurizmom i disekcijom grudne aorte. Balneoclimatologia 2017;41(1):196-209.  

    14. Koraćević GP, Velickovic Radovanovic M, Kostić TS, Lović DB, Zdravković MD, Đorđević D, Stojanovic M, Goran N, Koracevic M. Additional Nine Advantages of Amlodipine over Long-Acting Nitrates for Patients with Stable Angina Pectoris and Arterial Hypertension. Academia J Biotechnol 2017;5(8):112-117. doi:  10.15413/ajb.2017.0201

    15. Stojanovic M, Deljanin Ilic M, Ilic B, Ilic S, Djordjevic D, Petrovic D, Nikolic D. Transitory ST segment elevation during the exercise stress test. Global Journal for Research Analysis 2018;7(1):367-369. M53

    16. Stojanović M, Nikolić Pavlović I, Ilić B, Krstić I, Deljanin Ilić M. Ruptura interventrikularnog septum kao komplikacija infarkta miokarda. Balneoclimatologia 2019;43(1):469-476. 

    17. Stojanovic M, Ilic B, Deljanin-Ilic M, Ilic S, Petrovic D, Stojanovic S. Perimyocarditis versus Myocardial Infarction with ST Segment Elevation-MINOCA as a Starting Point. Indian Journal of Pharmacy Practice 2020;13(2):205. doi: 10.5530/ijopp.13.2.32

    18. Stojanović M, Stojanović S, Nedović J, Božilov S, Stamenković B, Jovanović J. Bekerova cista i njen analog na laktu. Balneoclimatologia 2020;44(1):75-82.

    19. Deljanin Ilić M, Stojanović M, Ilić S. Polne razilke u kardiovaskularnoj rehabilitaciji: da li žene imaju jednaku korist kao muškarci? Balneoclimatologia 2020;44(2):7-15. 

    20. Ilić B, Stojanović M, Deljanin Ilić M. Novine u dijagnozi i lečenju pacijenata sa akutnim koronarnim sindromom bez ST segment elevacije. Balneoclimatologia 2020;44(2):51-62.

    21. Stojanović M, Ilić B, Šarić S, Deljanin Ilić M, Marinković D, Simonović D, Hristov D, Igrutinović Novković J, Ilić S. Hiperkalemijom indukovana atrijalna fibrilacija – prikaz pacijenta. Balneoclimatologia 2020;44(2):205-212.

    22. Petrović D, Vuković A, Deljanin Ilić M, Mitić V, Simonović D, Stojanović S, Stojanović M. Kontrola temperature nakon srčanog zastoja u akutnom infarktu miokarda – prikaz bolesnika. Balneoclimatologia 2020;45(1):33-39.

    23. Stojanovic D, Stojanović M, Marjanovic D, Mitrovic G, Stalevic M, Stojanovic V. An everyday clinical challenge in the COVID 19 pandemic era–how to treat patients with pulmonary embolism and hemoptysis. Naučni časopis urgentne medicine-Halo 194 2022; 28(1): 18-23. doi:

    24. Stojanović M, Deljanin Ilic M, Ilić S. The effects of cardiovascular rehabilitation in patients with reduced, mildly reduced, and preserved ejection fraction-do they benefit equally?. SRCE i krvni sudovi 2022; 41(2): 39-43.

    25. Stojanovic M, Stojanovic D, Stojanovic V. Subclinical Hyperthyroidism is One of the Modifiable Risk Factors for Atrial Fibrillation. Journal of Exploratory Research in Pharmacology 2021. doi: 10.14218/JERP.2021.00054 

    26. Stojanovic M, Ilic B, Deljanin Ilic M, Marinkovic D, Stojanovic S, Ristic L, Stojanovic D, Ilic S, Petrovic D. Prikaz bolesnika sa Lajmskim perikarditisom. Balneoclimatologia 2021; 45(3): 41-50. 

Poslednji put izmenjeno četvrtak, 01 decembar 2022 12:17